Decitabine in Treating Patients With Myelodysplastic Syndrome

NCT00003361 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: decitabine

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]